Latest Insights on CELL
This Gene-Editing Stock Doubled in 3 Days July 6, 2021 Investment Opportunities, Technology, Winning Investor Daily Gene editing aims to cure diseases by replacing faulty genes with the healthy variant. That means no more monthly trips to the doctor.
100,000 People Are Profiting From This Million-Dollar Mistake — Join Them Today June 16, 2021 American Investor Today, Investing, Wealth Protection (4-minute read) The Wall Street machine does an excellent job of making even the smartest people feel like fools when investing. But we have a solution to help you invest smarter… 
No. 1 Trade for the Vaccine Boom April 8, 2021 American Investor Today, Investing, Technology (4-minute read) The new crop of mRNA vaccines is a testament to scientific achievement in health care. They’re part of a much larger trend that we’ve been monitoring for a while. Here’s how to profit…
NFT Hype Is Off the Charts — What You Should Buy Instead March 17, 2021 American Investor Today, Economy, Stocks (4-minute read) What’s going on in the art market right now? Nicole Zdzieba gives us an update. Plus, why we don’t bet on it for the long term…
“Fraud Built on Dozens of Lies” March 3, 2021 American Investor Today, Education, Investing (2-minute read) After a meteoric rise, Nikola has had a meteoric fall. We avoid stocks like this as a matter of course. Wall Street veteran Charles Mizrahi shows you how.